Hannah Lamb-Palmer

12

Feb2016

PMPRB NEW Report: Generics360 – Generic Drugs in Canada, 2014

As part of the National Prescription Drug Utilization Information System (NPDUIS), the Patented Medicine Prices Review Board (PMPRB) has recently released a report entitled, Generics360 – Generic Drugs in Canada, 2014. Through this newly named report series, the PMPRB monitors and reports on: the latest developments in generic drug pricing and markets ... Read More

12

Feb2016

Modifications to the Procedure for Filing a Drug Submission Application for Generic Drugs with INESSS

Since Québec is now participating in the pan-Canadian Pharmaceutical Alliance (pCPA), INESSS recently communicated that information sharing has now become necessary to ensure greater efficiency when conducting drug reviews. As of February 15, 2016, a supplementary document, supporting authorization of information sharing with pCPA, must accompany any drug submission application pertaining ... Read More

02

Feb2016

New Pilot Initiative: Increasing Opportunities for Clinical Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process

In November 2015, CADTH received stakeholder feedback on proposed changes to the pan-Canadian Oncology Drug Review (pCODR) program that would allow for broader clinician participation in the pCODR process. Feedback was received from three clinicians, three patient advocacy groups, three pharmaceutical companies, and two industry association groups. This stakeholder feedback ... Read More